Explore groundbreaking advancements in diabetes care at the Diabetes Technology Meeting 2024, held in Burlingame, California, from October 15-17, 2024. This premier event is designed for healthcare professionals, researchers, and technology developers, providing insight into the latest technologies and practices in diabetes management.
The Diabetes Technology Meeting is an ideal platform to gain in-depth knowledge about recent innovations in diabetes technology. The event will cover:
Learn about the role of AI in improving diabetes data analysis, diagnosis, and patient outcomes.
Discover the latest research on how CGMs are being used beyond blood glucose monitoring, including nutrition tracking for prediabetes and use by elite athletes.
Discussions will address patient data security, including HIPAA and FTC considerations.
Learn about the evidence needed by payers to support the use of diabetes devices and the impact of digital health tools on improving the patient experience.
Day 1 will kick off with Workshop A: Data Science and Artificial Intelligence, moderated by Shahid Shah. This session features a lineup of esteemed speakers, including Mark Clements, MD PhD CPI FAAP from CHILDREN’S MERCY HOSPITAL KANSAS, who will discuss the transformative potential of the Rising T1DE Alliance and the D-Data to transform care via the integration of CGM and other clinical data. Ali Cinar from the Illinois Institute of Technology will share insights on AI technologies that enhance diabetes treatment, amongst other sessions.
Following a break, Workshop A, Session 2: Real World Evidence for Diabetes Trials will take center stage, moderated by Sun Kim from Stanford University. This session will delve into the application of real-world data in diabetes care, including a presentation on harnessing the University of California, San Francisco’s health data warehouse to learn effective and safe treatments in Type 2 Diabetes, presented by Rohit Vashisht.
In the afternoon, Workshop B, Session 1: New Diagnostic Tests will highlight advancements in diabetes diagnostics, moderated by Dr. George A. Brooks from University of California, Berkeley and Koji Sode from University of North Carolina at Chapel Hill. The session will include presentations from Aaron Kowalski from Breakthrough T1D on current research programs and Zoe Quandt from University of California, San Francisco, who will discuss the role of antibodies in diagnosing diabetes.
Finally, Workshop B, Session 2: Drugs, Insulin, and Technology will be moderated by Guillermo Arreaza -Rubín from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and The National Institutes of Health. The session will include key presentations, including Alexander Fleming’s on solutions for age-related and drug-induced muscle loss. Day 1 will conclude with a Q&A session and poster presentations.
The meeting will feature multiple workshops:
A poster session will also be held to showcase the most promising current research programs and clinical trials in diabetes technology.
The Startup Showcase will feature innovative startups presenting their groundbreaking solutions in diabetes technology. Additionally, the Innovation Challenge will allow participants to pitch their ideas, providing valuable feedback from industry leaders. The showcase and challenge are great opportunities for networking and gaining visibility in the field.
The Diabetes Technology Meeting 2024 will be held at the Hyatt Regency San Francisco Airport (1333 Bayshore Highway, Burlingame, CA 94010), offering a comfortable and convenient location for all participants. Located just minutes away from San Francisco International Airport, the venue provides easy access and a range of amenities to make your stay enjoyable.
The Diabetes Technology Meeting is the leading event for diabetes technology professionals. From new product showcases to interactive sessions, you’ll leave with a wealth of knowledge to improve diabetes care practices. Whether you’re a researcher, healthcare provider, or technology enthusiast, this is your chance to be at the forefront of diabetes innovation.
The event is ideal for healthcare professionals, researchers, medical device developers, and anyone involved in diabetes care.
The meeting will cover topics like glucose monitoring, insulin delivery, FDA diabetes regulation, and other emerging technologies.
Click the Register Now button to sign up for the Diabetes Technology Meeting 2024.
At the Diabetes Technology Meeting (DTM), Orange Biomed will spotlight the urgent need to address A1C testing gaps in non-white populations. As part of the Startup Showcase and poster presentations, Orange Biomed will introduce the world’s first microfluidic-based A1C test—a groundbreaking innovation anticipated to receive FDA Clearance in 2025.
OBM rapid A1c provides an accurate, convenient way to test A1C, with a focus on addressing inaccuracies often found among non-white populations due to hemoglobin variants. With FDA clearance expected in 2025, Orange Biomed aims to bring this technology to healthcare providers and patients, ensuring equitable access to reliable diabetes management tools.
We are actively seeking collaborations with healthcare providers, researchers, and technology innovators. If you’re interested in partnering with us or want to set up a meeting during the Diabetes Technology Meeting, please reach out via our landing page.
Register Now to see Orange Biomed’s presentation and explore how our technology can revolutionize A1C testing. Book a Meeting to connect with our experts during the Diabetes Technology Meeting or to set up a virtual 1-1 meeting before or after the conference
Please leave us a message, and we will get in touch shortly.
"*" indicates required fields
If you are interested in a collaboration opportunity, email us at
Explore groundbreaking advancements in diabetes care at the Diabetes Technology Meeting 2024, held in Burlingame, California.
